Firma en Digital.CSIC (*)
Gil, Carmen
 
Otras firmas
Gil Ayuso-Gontán, Carmen
 
Centro o Instituto
CSIC - Centro de Investigaciones Biológicas (CIB)
 
Departamento
Biología Físico-Química. Grupo Química Médica y Biológica traslacional
 
Categoría Profesional
Investigadora Científica
 
Especialización
desarrollo de nuevos fármacos con aplicaciones en diferentes campos terapéuticos
 
Email
carmen.gil@csic.es
 
 
WoS ResearcherID - Publons
 
Scopus AuthorID
 
 
Otros identificadores (con url)
 

Resultados 21-40 de 126.

DerechosPreviewFecha Public.TítuloAutor(es)Tipo
21closedAccessaccesoRestringido.pdf.jpg2015Biology-oriented development of novel lipophilic antioxidants with neuroprotective activitySilva, T.; Bravo, J.; Summavielle, T.; Remião, Fernando; Pérez, Concepción CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Borges, Fernandaartículo
22openAccess4-oct-2014cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseasesMartínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID artículo
23openAccessNeurobiology of Disease_Cuevas_2024.pdf.jpgmar-2024Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosisCuevas, Eva P. CSIC ORCID ; Martínez-González, Loreto CSIC ORCID ; Gordillo, Clara; Tosat-Bitrian, Carlota CSIC ORCID ; Pérez de la Lastra, Carmen; Sáenz, Amets; Gil, Carmen CSIC ORCID ; Palomo, Valle CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
24openAccessnontypable_haemophilus_Garmendia.pdf.jpg13-may-2014Characterization of nontypable Haemophilus influenzae isolates recovered from adult patients with underlying chronic lung disease reveals genotypic and phenotypic traits associated with persistent infectionGarmendia, Juncal CSIC ORCID ; Viadas, Cristina CSIC; Euba, Begoña CSIC ORCID ; Gil, Carmen CSIC ORCID ; Bengoechea, José Antonio CSIC ORCIDartículo
25closedAccessaccesoRestringido.pdf.jpg2008CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application exampleCastro, Ana CSIC ORCID; Jerez, María José; Gil, Carmen CSIC ORCID ; Calderón, Félix CSIC; Doménech, Teresa; Nueda, Arsenio; Martínez Gil, Ana CSIC ORCID artículo
26closedAccessaccesoRestringido.pdf.jpg2004CODES/neural network model: A useful tool for in silico prediction of oral absorption and blood-brain barrier permeability of structurally diverse drugsDorronsoro Díaz, Isabel; Chana López, Antonio CSIC; Abasolo, Ibane; Castro, Ana CSIC ORCID; Gil, Carmen CSIC ORCID ; Stud Schlüter, Manfred; Martínez, A.artículo
27openAccessCognitive_Isabel_Preprint_2020.pdf.jpgdic-2020Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse modelCastro-Sánchez, Sara CSIC ORCID; Zaldívar-Díez, Josefa CSIC ORCID; Luengo, Enrique; López, Manuela G.; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Lastres-Becker, Isabel CSIC ORCIDartículo
28closedAccessaccesoRestringido.pdf.jpg2001CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: Clues for the design of phosphodiesterase 7 inhibitorsCastro, Ana CSIC ORCID; Abasolo, M. Inés; Gil, Carmen CSIC ORCID ; Segarra, Victor; Martínez Gil, Ana CSIC ORCID artículo
29closedAccessaccesoRestringido.pdf.jpg2013Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitisGonzález-García, C.; Bravo, Beatriz; Ballester, A.; Gõmez-Pérez, R.; Eguiluz, César; Redondo, Miriam CSIC; Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Ballester, S.artículo
30openAccessacs.jmedchem-Gil, C._2020.pdf.jpg8-jun-2020COVID-19: Drug targets and potential treatmentsGil, Carmen CSIC ORCID ; Ginex, Tiziana CSIC ORCID ; Maestro, Inés CSIC ORCID; Nozal, Vanesa CSIC ORCID; Barrado-Gil, Lucía CSIC ORCID; Cuesta-Geijo, Miguel Ángel CSIC ORCID; Urquiza, Jesús; Ramírez, David; Alonso, Covadonga; Campillo, Nuria E. CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
31closedAccessaccesoRestringido.pdf.jpg2014Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: Two relevant therapeutic targets for neurological disordersMorales-García, José A. CSIC ORCID; Palomo, Valle CSIC ORCID ; Redondo, Miriam CSIC; Alonso-Gil, Sandra CSIC; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Pérez Castillo, Ana CSIC ORCIDartículo
32closedAccessaccesoRestringido.pdf.jpg2005Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitorsCastro, Ana CSIC ORCID; Jerez, María José; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
33openAccessAntimicrob. Agents Chemother.-2018-Sebastián-Pérez-AAC.00603-18.pdf.jpg13-ago-2018Cyclic nucleotide specific phosphodiesterases as potential drug targets for anti-Leishmania therapySebastián-Pérez, Víctor; Hendrickx, Sarah; Munday, Jane C.; Kalejaiye, Titilola; Martínez Gil, Ana CSIC ORCID ; Campillo, Nuria E. CSIC ORCID ; Koning, Harry de; Caljon, Guy; Maes, Louis; Gil, Carmen CSIC ORCID artículo
34openAccessJournal of Enzyme Inhibition and Medicinal Chemistry_Sebastián-Pérez_ 2020.pdf.jpgdic-2020Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational toolsSebastián-Pérez, Víctor; García-Rubia, Alfonso CSIC; Seif el-Din, Sayed H.; Sabra, Abdel-Nasser A.; El-Lakkany, Naglaa M.; William, Samia; Blundell, Tom L.; Maes, Louis; Martínez Gil, Ana CSIC ORCID ; Campillo, Nuria E. CSIC ORCID ; Botros, Sanaa S.; Gil, Carmen CSIC ORCID artículo
35closedAccessaccesoRestringido.pdf.jpg2008Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthaseCastaño, Tania; Encinas, Arantxa; Pérez, Concepción CSIC ORCID; Castro, Ana CSIC ORCID; Campillo, Nuria E. CSIC ORCID ; Gil, Carmen CSIC ORCID artículo
36openAccessDirect laser interference_Guenther.pdf.jpg4-mar-2016Direct laser interference patterning for decreased bacterial attachmentGuenther, Denise; Valle Turrillas, Jaione CSIC ORCID; Burgui, Saioa CSIC ORCID; Gil, Carmen CSIC ORCID ; Solano Goñi, Cristina CSIC ORCID; Toledo-Arana, Alejandro CSIC ORCID ; Helbig, Ralf; Werner, Carsten; Lasa, Íñigo CSIC ORCID; Lasagni, Andrésartículo
37openAccessAAC_Sebastián-Pérez_2021.pdf.jpg20-ene-2021Discovery of amoebicidal compounds by combining computational and experimental approachesSebastián-Pérez, Víctor; Sifaoui, Ines; Reyes-Batlle, María; Domínguez-De Barros, Angélica; López-Arencibia, A.; Campillo, Nuria E. CSIC ORCID ; Piñero, J. E.; Lorenzo-Morales, Jacob; Gil, Carmen CSIC ORCID artículo
38openAccessFuture Med Chem_Sebastián-Pérez_2019.pdf.jpg2-ago-2019Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasisSebastián-Pérez, Víctor; Schroeder, Susanne; Munday, Jane C.; Meer, Tiffany van der; Zaldívar-Díez, Josefa CSIC ORCID; Siderius, Marco; Koning, Harry de; Martínez Gil, Ana CSIC ORCID ; Campillo, Nuria E. CSIC ORCID ; Leurs, Rob; Gil, Carmen CSIC ORCID artículo
39openAccessJournal of Enzyme Inhibition and Medicinal Chemistry_Rojas-Prats_2024.pdf.jpg11-ene-2024Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinaseRojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Gil, Carmen CSIC ORCID ; Ramírez, David; Martínez Gil, Ana artículo
40openAccessEOID_Postprint_2017.pdf.jpgabr-2017Drugs on clinical development for the treatment of amyotrophic lateral sclerosisMartínez Gil, Ana CSIC ORCID ; Palomo, Valle CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID artículo